PharPoint Research

PharPoint Research is a mid-sized, private contract research organization (CRO) that has carved out a strong reputation for its biometrics expertise and collaborative service model since its founding in 2007. The company differentiates itself through a commitment to transparency, strategic early planning, and consistently delivering on aggressive end-of-study timelines, particularly in database lock and topline results reporting. While it offers full-service CRO support, its core competitive advantage lies in its integrated data management and biostatistics teams, which it leverages to serve sponsors across various therapeutic areas, including rare diseases. PharPoint operates as a services business, generating revenue from client contracts, and its outlook is tied to the overall growth of clinical trial outsourcing and demand for high-quality, efficient biometrics partners.

Integrated clinical trial service platform emphasizing a quality-by-design (QbD) approach, with proprietary processes for rapid database build, lock, and statistical analysis. Features in-house EDC database builders and guaranteed delivery timelines for key biometrics deliverables.

PharPoint competes in the fragmented CRO market, primarily against large, full-service global CROs (IQVIA, PPD, ICON) and other specialized, mid-sized CROs. Its differentiation is based on a collaborative partnership model, deep biometrics expertise, and guaranteed rapid timelines, rather than global scale. It targets sponsors, particularly in biotech, who prioritize responsiveness and transparency over the extensive geographic footprint of larger competitors.